Global Malignant Melanoma Drug Sales Market Report 2016

December 2016 | 103 pages | ID: GD84AFAB9E3EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Malignant Melanoma Drug

Revenue, means the sales value of Malignant Melanoma Drug

This report studies sales (consumption) of Malignant Melanoma Drug in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Merck
• Navidea Biopharmaceuticals
• Decartis
• Ono Pharmaceutical
• Pfizer
• Roche

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Malignant Melanoma Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Immunotherapy
• Targeted therapy
• Others

Split by applications, this report focuses on sales, market share and growth rate of Malignant Melanoma Drug in each application, can be divided into

• Hospital use
• Clinic use
• Application 3

Contents

Global Malignant Melanoma Drug Sales Market Report 2016

1 MALIGNANT MELANOMA DRUG OVERVIEW

1.1 Product Overview and Scope of Malignant Melanoma Drug
1.2 Classification of Malignant Melanoma Drug
  1.2.1 Immunotherapy
  1.2.2 Targeted therapy
  1.2.3 Others
1.3 Application of Malignant Melanoma Drug
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Application
1.4 Malignant Melanoma Drug Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Malignant Melanoma Drug (2011-2021)
  1.5.1 Global Malignant Melanoma Drug Sales and Growth Rate (2011-2021)
  1.5.2 Global Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL MALIGNANT MELANOMA DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Malignant Melanoma Drug Market Competition by Manufacturers
  2.1.1 Global Malignant Melanoma Drug Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Malignant Melanoma Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Malignant Melanoma Drug (Volume and Value) by Type
  2.2.1 Global Malignant Melanoma Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Global Malignant Melanoma Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Malignant Melanoma Drug (Volume and Value) by Regions
  2.3.1 Global Malignant Melanoma Drug Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Malignant Melanoma Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Malignant Melanoma Drug (Volume) by Application

3 UNITED STATES MALIGNANT MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Malignant Melanoma Drug Sales and Value (2011-2016)
  3.1.1 United States Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
  3.1.2 United States Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
  3.1.3 United States Malignant Melanoma Drug Sales Price Trend (2011-2016)
3.2 United States Malignant Melanoma Drug Sales and Market Share by Manufacturers
3.3 United States Malignant Melanoma Drug Sales and Market Share by Type
3.4 United States Malignant Melanoma Drug Sales and Market Share by Application

4 CHINA MALIGNANT MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Malignant Melanoma Drug Sales and Value (2011-2016)
  4.1.1 China Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
  4.1.2 China Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
  4.1.3 China Malignant Melanoma Drug Sales Price Trend (2011-2016)
4.2 China Malignant Melanoma Drug Sales and Market Share by Manufacturers
4.3 China Malignant Melanoma Drug Sales and Market Share by Type
4.4 China Malignant Melanoma Drug Sales and Market Share by Application

5 EUROPE MALIGNANT MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Malignant Melanoma Drug Sales and Value (2011-2016)
  5.1.1 Europe Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
  5.1.2 Europe Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Malignant Melanoma Drug Sales Price Trend (2011-2016)
5.2 Europe Malignant Melanoma Drug Sales and Market Share by Manufacturers
5.3 Europe Malignant Melanoma Drug Sales and Market Share by Type
5.4 Europe Malignant Melanoma Drug Sales and Market Share by Application

6 JAPAN MALIGNANT MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Malignant Melanoma Drug Sales and Value (2011-2016)
  6.1.1 Japan Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
  6.1.2 Japan Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Malignant Melanoma Drug Sales Price Trend (2011-2016)
6.2 Japan Malignant Melanoma Drug Sales and Market Share by Manufacturers
6.3 Japan Malignant Melanoma Drug Sales and Market Share by Type
6.4 Japan Malignant Melanoma Drug Sales and Market Share by Application

7 GLOBAL MALIGNANT MELANOMA DRUG MANUFACTURERS ANALYSIS

7.1 Bristol-Myers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bristol-Myers Squibb Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Enzon Pharmaceuticals
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 103 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Enzon Pharmaceuticals Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Exelixis
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 125 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Exelixis Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Merck
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Merck Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Navidea Biopharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Navidea Biopharmaceuticals Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Decartis
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Decartis Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Ono Pharmaceutical
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Ono Pharmaceutical Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Pfizer
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Pfizer Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Roche
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Roche Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview

8 MALIGNANT MELANOMA DRUG MAUFACTURING COST ANALYSIS

8.1 Malignant Melanoma Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Malignant Melanoma Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Malignant Melanoma Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Malignant Melanoma Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MALIGNANT MELANOMA DRUG MARKET FORECAST (2016-2021)

12.1 Global Malignant Melanoma Drug Sales, Revenue Forecast (2016-2021)
12.2 Global Malignant Melanoma Drug Sales Forecast by Regions (2016-2021)
12.3 Global Malignant Melanoma Drug Sales Forecast by Type (2016-2021)
12.4 Global Malignant Melanoma Drug Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Malignant Melanoma Drug
Table Classification of Malignant Melanoma Drug
Figure Global Sales Market Share of Malignant Melanoma Drug by Type in 2015
Figure Immunotherapy Picture
Figure Targeted therapy Picture
Figure Others Picture
Table Applications of Malignant Melanoma Drug
Figure Global Sales Market Share of Malignant Melanoma Drug by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure United States Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)
Figure China Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)
Figure Europe Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)
Figure Japan Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)
Figure Global Malignant Melanoma Drug Sales and Growth Rate (2011-2021)
Figure Global Malignant Melanoma Drug Revenue and Growth Rate (2011-2021)
Table Global Malignant Melanoma Drug Sales of Key Manufacturers (2011-2016)
Table Global Malignant Melanoma Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Malignant Melanoma Drug Sales Share by Manufacturers
Figure 2016 Malignant Melanoma Drug Sales Share by Manufacturers
Table Global Malignant Melanoma Drug Revenue by Manufacturers (2011-2016)
Table Global Malignant Melanoma Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Malignant Melanoma Drug Revenue Share by Manufacturers
Table 2016 Global Malignant Melanoma Drug Revenue Share by Manufacturers
Table Global Malignant Melanoma Drug Sales and Market Share by Type (2011-2016)
Table Global Malignant Melanoma Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Malignant Melanoma Drug by Type (2011-2016)
Figure Global Malignant Melanoma Drug Sales Growth Rate by Type (2011-2016)
Table Global Malignant Melanoma Drug Revenue and Market Share by Type (2011-2016)
Table Global Malignant Melanoma Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Malignant Melanoma Drug by Type (2011-2016)
Figure Global Malignant Melanoma Drug Revenue Growth Rate by Type (2011-2016)
Table Global Malignant Melanoma Drug Sales and Market Share by Regions (2011-2016)
Table Global Malignant Melanoma Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Malignant Melanoma Drug by Regions (2011-2016)
Figure Global Malignant Melanoma Drug Sales Growth Rate by Regions (2011-2016)
Table Global Malignant Melanoma Drug Revenue and Market Share by Regions (2011-2016)
Table Global Malignant Melanoma Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Malignant Melanoma Drug by Regions (2011-2016)
Figure Global Malignant Melanoma Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Malignant Melanoma Drug Sales and Market Share by Application (2011-2016)
Table Global Malignant Melanoma Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Malignant Melanoma Drug by Application (2011-2016)
Figure Global Malignant Melanoma Drug Sales Growth Rate by Application (2011-2016)
Figure United States Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
Figure United States Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
Figure United States Malignant Melanoma Drug Sales Price Trend (2011-2016)
Table United States Malignant Melanoma Drug Sales by Manufacturers (2011-2016)
Table United States Malignant Melanoma Drug Market Share by Manufacturers (2011-2016)
Table United States Malignant Melanoma Drug Sales by Type (2011-2016)
Table United States Malignant Melanoma Drug Market Share by Type (2011-2016)
Table United States Malignant Melanoma Drug Sales by Application (2011-2016)
Table United States Malignant Melanoma Drug Market Share by Application (2011-2016)
Figure China Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
Figure China Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
Figure China Malignant Melanoma Drug Sales Price Trend (2011-2016)
Table China Malignant Melanoma Drug Sales by Manufacturers (2011-2016)
Table China Malignant Melanoma Drug Market Share by Manufacturers (2011-2016)
Table China Malignant Melanoma Drug Sales by Type (2011-2016)
Table China Malignant Melanoma Drug Market Share by Type (2011-2016)
Table China Malignant Melanoma Drug Sales by Application (2011-2016)
Table China Malignant Melanoma Drug Market Share by Application (2011-2016)
Figure Europe Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
Figure Europe Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
Figure Europe Malignant Melanoma Drug Sales Price Trend (2011-2016)
Table Europe Malignant Melanoma Drug Sales by Manufacturers (2011-2016)
Table Europe Malignant Melanoma Drug Market Share by Manufacturers (2011-2016)
Table Europe Malignant Melanoma Drug Sales by Type (2011-2016)
Table Europe Malignant Melanoma Drug Market Share by Type (2011-2016)
Table Europe Malignant Melanoma Drug Sales by Application (2011-2016)
Table Europe Malignant Melanoma Drug Market Share by Application (2011-2016)
Figure Japan Malignant Melanoma Drug Sales and Growth Rate (2011-2016)
Figure Japan Malignant Melanoma Drug Revenue and Growth Rate (2011-2016)
Figure Japan Malignant Melanoma Drug Sales Price Trend (2011-2016)
Table Japan Malignant Melanoma Drug Sales by Manufacturers (2011-2016)
Table Japan Malignant Melanoma Drug Market Share by Manufacturers (2011-2016)
Table Japan Malignant Melanoma Drug Sales by Type (2011-2016)
Table Japan Malignant Melanoma Drug Market Share by Type (2011-2016)
Table Japan Malignant Melanoma Drug Sales by Application (2011-2016)
Table Japan Malignant Melanoma Drug Market Share by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Malignant Melanoma Drug Global Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Enzon Pharmaceuticals Malignant Melanoma Drug Global Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Exelixis Malignant Melanoma Drug Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Malignant Melanoma Drug Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Malignant Melanoma Drug Global Market Share (2011-2016)
Table Navidea Biopharmaceuticals Basic Information List
Table Navidea Biopharmaceuticals Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Navidea Biopharmaceuticals Malignant Melanoma Drug Global Market Share (2011-2016)
Table Decartis Basic Information List
Table Decartis Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Decartis Malignant Melanoma Drug Global Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information List
Table Ono Pharmaceutical Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ono Pharmaceutical Malignant Melanoma Drug Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Malignant Melanoma Drug Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Malignant Melanoma Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Malignant Melanoma Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Malignant Melanoma Drug
Figure Manufacturing Process Analysis of Malignant Melanoma Drug
Figure Malignant Melanoma Drug Industrial Chain Analysis
Table Raw Materials Sources of Malignant Melanoma Drug Major Manufacturers in 2015
Table Major Buyers of Malignant Melanoma Drug
Table Distributors/Traders List
Figure Global Malignant Melanoma Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Malignant Melanoma Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Malignant Melanoma Drug Sales Forecast by Regions (2016-2021)
Table Global Malignant Melanoma Drug Sales Forecast by Type (2016-2021)
Table Global Malignant Melanoma Drug Sales Forecast by Application (2016-2021)